tiprankstipranks
Trending News
More News >
Shandong Xinhua Pharmaceutical Gains Approval for Epalrestat Tablets License Transfer
PremiumCompany AnnouncementsShandong Xinhua Pharmaceutical Gains Approval for Epalrestat Tablets License Transfer
1M ago
Shandong Xinhua Pharmaceutical Reports Q1 2025 Financial Results
Premium
Company Announcements
Shandong Xinhua Pharmaceutical Reports Q1 2025 Financial Results
1M ago
Shandong Xinhua Pharmaceutical’s Aspirin Tablets Gain Approval
Premium
Company Announcements
Shandong Xinhua Pharmaceutical’s Aspirin Tablets Gain Approval
1M ago
Shandong Xinhua’s Aminophylline Tablets Pass Key Quality Evaluation
PremiumCompany AnnouncementsShandong Xinhua’s Aminophylline Tablets Pass Key Quality Evaluation
2M ago
Shandong Xinhua Pharmaceutical Gains Approval for Eszolam Tablets License Transfer
Premium
Company Announcements
Shandong Xinhua Pharmaceutical Gains Approval for Eszolam Tablets License Transfer
2M ago
Shandong Xinhua Pharmaceutical Releases 2024 Financial Results
Premium
Company Announcements
Shandong Xinhua Pharmaceutical Releases 2024 Financial Results
2M ago
Xinhua Pharmaceutical Gains Approval for Clopidogrel Tablets Marketing Transfer
PremiumCompany AnnouncementsXinhua Pharmaceutical Gains Approval for Clopidogrel Tablets Marketing Transfer
3M ago
Xinhua Pharmaceutical Gains Approval for Rosuvastatin License Transfer
Premium
Company Announcements
Xinhua Pharmaceutical Gains Approval for Rosuvastatin License Transfer
5M ago
Shandong Xinhua Pharmaceutical Secures Drug Registration for Empagliflozin Tablets
Premium
Company Announcements
Shandong Xinhua Pharmaceutical Secures Drug Registration for Empagliflozin Tablets
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100